Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Biologics in Psoriasis
Biologics have revolutionized the treatment of psoriasis, offering targeted therapies that address the underlying mechanisms of this chronic autoimmune condition. Unlike traditional systemic treatments, which broadly suppress the immune system, biologics specifically target key molecules involved in the inflammatory pathways of psoriasis. This precision has resulted in significant improvements in efficacy and safety, providing relief for patients with moderate to severe psoriasis who have not responded well to conventional therapies.
The most commonly used biologics for psoriasis include TNF inhibitors, IL-12/23 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. These drugs have demonstrated remarkable success in reducing the severity of psoriatic lesions and achieving long-term skin clearance. Clinical trials and real-world studies have shown that many patients experience rapid and sustained improvements, with some achieving near-complete remission of their symptoms. This has significantly enhanced the quality of life for those living with psoriasis.
Therefore, get an overall knowledge of biologics in psoriasis
See More Webinars @ Hidoc Webinars
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
Research uncovers hidden Australian skin cancer epidemic
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation